Indian Drugmakers Rattled by Trump's Proposed 100% Levy on Generic Drugs; Portuguese Politics Discussed

Indian pharmaceutical companies are expressing significant concern and uncertainty following former President Donald Trump's proposal to impose tariffs, potentially up to 200%, on generic drug imports. Trump stated that non-patented drugmakers would have two years to move production to the U.S. or face a 100% import tariff, which would double a year later, severely impacting India's dominant position in the global generic drug market. Meanwhile, a Portuguese article discusses careerists in politics, using metaphors of bulls and horses to describe vitality, which is a separate topic.